| Pharmaceutical Information |
| Drug Name |
Florbetaben f-18 |
| Drug ID |
BADD_D00905 |
| Description |
Florbetaben is a fluorine-18 (18F)-labeled stilbene derivative used for Positron Emission Tomography (PET) imaging of the brain. It is used for the non-invasive detection of the density of ß-amyloid neuritic plaques in the brain of adult patients with cognitive impairment. |
| Indications and Usage |
Florbetaben is a radioactive diagnostic agent indicated for Positron Emission Tomography (PET) imaging of the brain to estimate β-amyloid neuritic plaque density in adult patients with cognitive impairment who are being evaluated for Alzheimer’s Disease (AD) and other causes of cognitive decline. |
| Marketing Status |
Not Available |
| ATC Code |
V09AX06 |
| DrugBank ID |
DB09148
|
| KEGG ID |
D10002
|
| MeSH ID |
C527756
|
| PubChem ID |
11501341
|
| TTD Drug ID |
Not Available
|
| NDC Product Code |
Not Available |
| Synonyms |
4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene | florbetaben | BAY94 9172 | BAY94-9172 | BAY 94-9172 | 18F-florbetaben | 18F-BAY94-9172 |
|
| Chemical Information |
| Molecular Formula |
C21H26FNO3 |
| CAS Registry Number |
902143-01-5 |
| SMILES |
CNC1=CC=C(C=C1)C=CC2=CC=C(C=C2)OCCOCCOCCF |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
